Almost 4 billion prescriptions for medications were written in the United States in 2010, an all-time high.
Each single dose prefilled syringe contains 300mcg (1500 IU) of Rho(D) immune globulin (human). This is the dose for the indications associated w/ pregnancy at or beyond 13 weeks unless there is clinical or laboratory evidence of a fetal-maternal hemorrhage (FMH) >15mL of Rh-positive RBCs. MICRhoGAM. Each single dose prefilled syringe of MICRhoGAM contains 50mcg (250 IU) of Rho(D) immune globulin (human).
Women are most likely to be exposed to the fetusâ blood during the last three months of pregnancy and at delivery. Therefore, during pregnancy women are usually given a dose of RhoGAMÂ® at approximately 28 weeks gestation and then receive another dose within 72 hours of birth, if the baby has an Rh- positive blood type.